FOR IMMEDIATE RELEASE MESA, Ariz. — December 22, 2022 Recently our researchers discovered some very novel practices being undertaken in China, where Uterine Artery Embolization (UAE), which is usually reserved for the treatment of Uterine Fibroids, is being used to treat Cesarean Scar Ectopic Pregnancies (CSP). We assembled the data we could find to offer…
FOR IMMEDIATE RELEASE MESA, Ariz. — December 8, 2022 The Marchand Institute noted this week a brilliantly written new report “Twenty-First Century Illicit Drugs and Their Discontents: The Potential Risks that Cannabis Use by Pregnant and Nursing Women Pose to Their Children,” by Paul J. Larkin. This report and opinion on the status of cannabis…
FOR IMMEDIATE RELEASE MESA, Ariz. — August 13, 2022 We are delighted to announce that two of our research papers, “Meta-Analysis of Veress Needle Entry Versus Direct Trocar Entry in Gynecologic Surgery” and “Meta-Analysis Of Laparoscopic Radical Hysterectomy Vs. Robotic Assisted Radical Hysterectomy For Early Stage Cervical Cancer” have been accepted for oral presentation at…
FOR IMMEDIATE RELEASE MESA, Ariz. — August 2, 2022 You can find our latest publication, a narrative review of popular methods of sterilization, online at the website for Minerva Medica. The listing for this new publication on the US PubMed website is here: https://pubmed.ncbi.nlm.nih.gov/35912465/ About Dr. Greg Marchand Greg J. Marchand, MD, FACS, FACOG, FICS,…
FOR IMMEDIATE RELEASE MESA, Ariz. — July 24, 2022 Our newest article gets back to the basics of MIGS with “Systematic review and meta-analysis of Veress needle entry versus direct trocar entry in gynecologic surgery,” which is now available free online at BMJ Surgery, Intervention and Health Technologies. You can see the full article here: …
FOR IMMEDIATE RELEASE MESA, Ariz. — March 15, 2022 Since 2019, The Marchand Institute has displayed a paragraph on all publications proudly stating their dedication to diversity, inclusion, and the maintenance of a workplace free of racism and sexism. This declaration, in accordance with our not-for-profit mission for women’s health, is very much a part…
FOR IMMEDIATE RELEASE MESA, Ariz. — January 7, 2022 About Dr. Greg Marchand Greg J. Marchand, MD, FACS, FACOG, FICS, is a dual board-certified obstetrician-gynecologist and minimally invasive gynecologic surgeon practising in Mesa, Arizona. He holds the ABOG Focused Practice Designation in Minimally Invasive Gynecologic Surgery and directs the Marchand Institute for Minimally Invasive Surgery,…
FOR IMMEDIATE RELEASE MESA, Ariz. — December 27, 2021 Dr. Marchand recently performed the largest meta-analysis to date on power morcellation in hysterectomy and myomectomy. The paper has recently been published online by a major medical journal. You can read the abstract online on NIH’s PubMed Website here: https://pubmed.ncbi.nlm.nih.gov/34955114/ You can also read the full…
FOR IMMEDIATE RELEASE MESA, Ariz. — December 27, 2021 The largest ever meta analysis looking at isthmocele formation related to cesarean section techniques was completed here at the Marchand Institute and was just published by a major medical journal and is now available online! You can read the abstract on NIH’s PubMed website here: https://pubmed.ncbi.nlm.nih.gov/34955322/…
FOR IMMEDIATE RELEASE MESA, Ariz. — December 7, 2021 Published online today in PubMed is our latest research on the use of Hyoscine to improve patient comfort in office hysteroscopy. You can find the article in PubMed here. About Dr. Greg Marchand Greg J. Marchand, MD, FACS, FACOG, FICS, is a dual board-certified obstetrician-gynecologist and…